Challenges to liver transplantation and strategies to improve outcomes

Gastroenterology

Volumn 148, Issue 2, 2015, Pages 307-323

  Dutkowski, Philipp ^a   Linecker, Michael ^a   Deoliveira, Michelle L ^a   Müllhaupt, Beat ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cholabgiocarcinoma; HCC; Hepatitis C; Liver Transplantation; Machine Perfusion

Indexed keywords

LEDIPASVIR; RIBAVIRIN; SOFOSBUVIR;

ALCOHOL LIVER DISEASE; ARTICLE; BILE DUCT CARCINOMA; DECOMPENSATED LIVER CIRRHOSIS; DONOR SELECTION; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT; LIVER INJURY; LIVER PERFUSION; LIVER PRESERVATION; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MACHINE LIVER PERFUSION; NONALCOHOLIC FATTY LIVER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; PERFUSION; PROCEDURES;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HEPATITIS C; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER REGENERATION; LIVER TRANSPLANTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PERFUSION;

EID: 84921364759     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.08.045     Document Type: Review

References (182)

1. V.G. Agopian, H. Petrowsky, and F.M. Kaldas The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center Ann Surg 258 2013 409 421
2. R. Adam, V. Karam, and V. Delvart Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR) J Hepatol 57 2012 675 688
3. P. Dutkowski, O. De Rougemont, and B. Mullhaupt Current and future trends in liver transplantation in Europe Gastroenterology 138 2010 802 809.e1-4
4. P.A. Clavien, B. Mullhaupt, and B.C. Pestalozzi Do we need a center approach to treat patients with liver diseases? J Hepatol 44 2006 639 642
5. P. Dutkowski, C.E. Oberkofler, and M. Bechir The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis Liver Transpl 17 2011 674 684
6. C.L. Chen, C.S. Kabiling, and A.M. Concejero Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol 10 2013 746 751
7. M.R. Charlton, J.M. Burns, and R.A. Pedersen Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
8. V.G. Agopian, F.M. Kaldas, and J.C. Hong Liver transplantation for nonalcoholic steatohepatitis: the new epidemic Ann Surg 256 2012 624 633
9. W.R. Kim, J.M. Smith, and M.A. Skeans OPTN/SRTR 2012 Annual Data Report: liver Am J Transplant 14 suppl 1 2014 69 96
10. European Liver Transplant Registry. Overall indication and results 2014. Available at: http://www.eltr.org/Overall-indication-and-results.html. Accessed May 1, 2014.
11. R.J. Wong, R. Cheung, and A. Ahmed Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S Hepatology 59 2014 2188 2195
12. X. Wang, J. Li, and D.R. Riaz Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis Clin Gastroenterol Hepatol 12 2014 394 402.e1
13. Y. Maor-Kendler, K.P. Batts, and L.J. Burgart Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases Transplantation 70 2000 292 297
14. L.B. VanWagner, M. Bhave, and H.S. Te Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events Hepatology 56 2012 1741 1750
15. G. Ribaric, J.N. Buchwald, and T.W. McGlennon Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis Obes Surg 24 2014 437 455
16. T.N. Weingarten, J.M. Swain, and M.L. Kendrick Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery Obes Surg 21 2011 1714 1720
17. J.D. Mosko, and G.C. Nguyen Increased perioperative mortality following bariatric surgery among patients with cirrhosis Clin Gastroenterol Hepatol 9 2011 897 901
18. J.K. Heimbach, K.D. Watt, and J.J. Poterucha Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease Am J Transplant 13 2013 363 368
19. P. Burra, M. Senzolo, and R. Adam Liver transplantation for alcoholic liver disease in Europe: A study from the ELTR (European Liver Transplant Registry) Am J Transplant 10 2010 138 148
20. A. De Gottardi, L. Spahr, and P. Gelez A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years Arch Intern Med 167 2007 1183 1188
21. M.A. Dew, A.F. DiMartini, and J. Steel Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs Liver Transpl 14 2008 159 172
22. W.R. Yates, M. Martin, and D. LaBrecque A model to examine the validity of the 6-month abstinence criterion for liver transplantation Alcohol Clin Exp Res 22 1998 513 517
23. European Association for the Study of the Liver EASL clinical practical guidelines: management of alcoholic liver disease J Hepatol 57 2012 399 420
24. Lucey MR. Liver transplantation for alcoholic liver disease. Nat Rev Gastroenterol Hepatol (in press).
25. C. Vanlemmens, V. Di Martino, and C. Milan Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial Ann Intern Med 150 2009 153 161
26. R. Parker, M.J. Armstrong, and C. Corbett Alcohol and substance abuse in solid-organ transplant recipients Transplantation 96 2013 1015 1024
27. P. Mathurin, J. O'Grady, and R.L. Carithers Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 2011 255 260
28. A.J. Bathgate, and UK Liver Transplant Units Recommendations for alcohol-related liver disease Lancet 367 2006 2045 2046
29. P. Mathurin, C. Moreno, and D. Samuel Early liver transplantation for severe alcoholic hepatitis N Engl J Med 365 2011 1790 1800
30. A. Louvet, S. Naveau, and M. Abdelnour The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
31. M. Charlton, K. Ruppert, and S.H. Belle Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database Liver Transpl 10 2004 1120 1130
32. L.M. Forman, J.D. Lewis, and J.A. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
33. J.A. Carrion, M. Navasa, and M. Garcia-Retortillo Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study Gastroenterology 132 2007 1746 1756
34. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat Rev Microbiol 5 2007 453 463
35. B.R. Bacon, S.C. Gordon, and E. Lawitz Boceprevir for previously treated chronic HCV genotype 1 infection N Engl J Med 364 2011 1207 1217
36. V. Saxena, M.M. Manos, and H.S. Yee Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis Aliment Pharmacol Ther 39 2014 1213 1224
37. E. Hulskotte, S. Gupta, and F. Xuan Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers Hepatology 56 2012 1622 1630
38. E. Lawitz, A. Mangia, and D. Wyles Sofosbuvir for previously untreated chronic hepatitis C infection N Engl J Med 368 2013 1878 1887
39. S. Zeuzem, G.M. Dusheiko, and R. Salupere Sofosbuvir and ribavirin in HCV genotypes 2 and 3 N Engl J Med 370 2014 1993 2001
40. M.P. Curry, X. Forns, and R.T. Chung Pretransplant sofosbuvir and ribavirin to prevent recurrence of HCV infection after liver transplantation Hepatology 58 suppl 1 2013 314A 315A
41. American Association for the Study of Liver Diseases. Recommendations for testing, managing, and treating hepatitis C 2014. Available at: www.hcvguidelines.org.
42. European Association for the Study of the Liver. Recommendations on treatment of hepatitis C. 2014.
43. D. Samuel, M. Charlton, and E. Gane Sofosbuvir and ribavirin for the treatment of recurrent hepatitis c infection after liver transplantation: results of a prospective, multicenter study J Hepatol 60 suppl 1 2014 S499
44. X. Forns, M. Prieto, and M. Charlton Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C including fibrosing cholestatic hepatitis following liver transplantation J Hepatol 60 suppl 1 2014 S26
45. N. Afdhal, S. Zeuzem, and P. Kwo Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection N Engl J Med 370 2014 1889 1898
46. N. Afdhal, K.R. Reddy, and D.R. Nelson Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection N Engl J Med 370 2014 1483 1493
47. F. Poordad, C. Hezode, and R. Trinh ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis N Engl J Med 370 2014 1973 1982
48. J.J. Feld, K.V. Kowdley, and E. Coakley Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin N Engl J Med 370 2014 1594 1603
49. S. Zeuzem, I.M. Jacobson, and T. Baykal Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin N Engl J Med 370 2014 1604 1614
50. E.J. Gane, R.H. Hyland, and D. An Sofosbuvir/ledipasvir fixed dose combination is safe and effective in difficult-to-treat populations including genotype-3 patients, decompensated genotype-1 patients, and genotype-1 patients with prior sofosbuvir treatment experience J Hepatol 60 suppl 1 2014 S3 S4
51. P. Kwo, P. Mantry, and E. Coakley Results of the phase 2 study M12-999: interferon-free regimen of ABT-450/R/ABT-267 + ABT-333 + ribavirin in liver transplant recipients with recurrent HCV genotype 1 infection J Hepatol 60 suppl 1 2014 S47
52. A.M. Pellicelli, R. Lionetti, and M. Montalbano Sofosbuvir and daclatasvir for recurrent hepatitis C after liver transplantation: potent antiviral activity but lack of clinical benefit if treatment is given too late J Hepatol 60 suppl 1 2014 S532 S533
53. R.J. Fontana, E.A. Hughes, and M. Bifano Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C Am J Transplant 13 2013 1601 1605
54. T.E. Starzl, and J.J. Fung Themes of liver transplantation Hepatology 51 2010 1869 1884
55. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
56. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
57. G.J. Gores, D.M. Nagorney, and C.B. Rosen Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 47 2007 455 459
58. S. Darwish Murad, W.R. Kim, and D.M. Harnois Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers Gastroenterology 143 2012 88 98.e3 quiz e14
59. R.H. Wiesner, R.B. Freeman, and D.C. Mulligan Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy Gastroenterology 127 suppl 1 2004 S261 S267
60. F.Y. Yao Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria Am J Transplant 8 2008 1982 1989
61. M. Schwartz Liver transplantation in patients with hepatocellular carcinoma Liver Transpl 10 suppl 1 2004 S81 S85
62. D. Samuel, M. Colombo, and H. El-Serag Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma Liver Transpl 17 suppl 2 2011 S6 S13
63. J. Belghiti, and D. Fuks Liver resection and transplantation in hepatocellular carcinoma Liver Cancer 1 2012 71 82
64. P.A. Clavien, M. Lesurtel, and P.M. Bossuyt Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
65. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
66. V. Mazzaferro, J.M. Llovet, and R. Miceli Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
67. V. Mazzaferro, S. Bhoori, and C. Sposito Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience Liver Transpl 17 suppl 2 2011 S44 S57
68. D. DuBay, C. Sandroussi, and L. Sandhu Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion Ann Surg 253 2011 166 172
69. S.G. Lee, S. Hwang, and D.B. Moon Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center Liver Transpl 14 2008 935 945
70. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
71. F.Y. Yao, L. Xiao, and N.M. Bass Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587 2596
72. J.P. Duffy, A. Vardanian, and E. Benjamin Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 509 discussion 509-511
73. T. Decaens, F. Roudot-Thoraval, and S. Hadni-Bresson Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time Liver Transpl 12 2006 1761 1769
74. F.Y. Yao, R. Hirose, and J.M. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514
75. F. D'Amico, M. Schwartz, and A. Vitale Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria Liver Transpl 15 2009 1278 1287
76. Y. Sugawara, S. Tamura, and M. Makuuchi Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series Dig Dis 25 2007 310 312
77. S.S. Zheng, X. Xu, and J. Wu Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732
78. Y. Takada, and S. Uemoto Liver transplantation for hepatocellular carcinoma: the Kyoto experience J Hepatobiliary Pancreat Sci 17 2010 527 532
79. S. Lee, C. Ahn, and T. Ha Liver transplantation for hepatocellular carcinoma: Korean experience J Hepatobiliary Pancreat Sci 17 2010 539 547
80. J.M. Llovet, M. Schwartz, and V. Mazzaferro Resection and liver transplantation for hepatocellular carcinoma Semin Liver Dis 25 2005 181 200
81. S. Hwang, S.G. Lee, and Y.J. Lee Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe Liver Transpl 12 2006 920 927
82. S. Todo, H. Furukawa Japanese Study Group on Organ Transplantation Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg 240 2004 451 459 discussion 459-461
83. S. Hwang, S.G. Lee, and J.W. Joh Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations Liver Transpl 11 2005 1265 1272
84. C.M. Lo, S.T. Fan, and C.L. Liu Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma Br J Surg 94 2007 78 86
85. R.M. Ghobrial, C.E. Freise, and J.F. Trotter Donor morbidity after living donation for liver transplantation Gastroenterology 135 2008 468 476
86. E.A. Pomfret, J.P. Lodge, and F.G. Villamil Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations Liver Transpl 17 suppl 2 2011 S128 S132
87. A. Nakeeb, H.A. Pitt, and T.A. Sohn Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 1996 463 473 discussion 473-475
88. B. Blechacz, M. Komuta, and T. Roskams Clinical diagnosis and staging of cholangiocarcinoma Nat Rev Gastroenterol Hepatol 8 2011 512 522
89. M.L. DeOliveira, S.C. Cunningham, and J.L. Cameron Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 2007 755 762
90. J.C. Hong, H. Petrowsky, and F.M. Kaldas Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma J Am Coll Surg 212 2011 514 520 discussion 520-521
91. J.C. Hong, C.M. Jones, and J.P. Duffy Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center Arch Surg 146 2011 683 689
92. B.S. Fu, T. Zhang, and H. Li The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience Eur Surg Res 47 2011 218 221
93. G.C. Sotiropoulos, G.M. Kaiser, and H. Lang Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience Transplant Proc 40 2008 3194 3195
94. G. Sapisochin, C. Rodriguez de Lope, and M. Gastaca "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant 14 2014 660 667
95. G. Sapisochin, N. Fidelman, and J.P. Roberts Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma Liver Transpl 17 2011 934 942
96. R. Robles, J. Figueras, and V.S. Turrion Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma Ann Surg 239 2004 265 271
97. P. Ghali, P.J. Marotta, and E.M. Yoshida Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience Liver Transpl 11 2005 1412 1416
98. D.J. Rea, J.K. Heimbach, and C.B. Rosen Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma Ann Surg 242 2005 451 458 discussion 458-461
99. D. Sudan, A. DeRoover, and S. Chinnakotla Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma Am J Transplant 2 2002 774 779
100. G.J. Gores, R.G. Gish, and D. Sudan Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia Liver Transpl 12 suppl 3 2006 S95 S97
101. S. Rizvi, and G.J. Gores Pathogenesis, diagnosis, and management of cholangiocarcinoma Gastroenterology 145 2013 1215 1229
102. M.L. Deoliveira, R.D. Schulick, and Y. Nimura New staging system and a registry for perihilar cholangiocarcinoma Hepatology 53 2011 1363 1371
103. R. Wiesner, E. Edwards, and R. Freeman Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
104. P.S. Kamath, and W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
105. T.J. Weismuller, P. Fikatas, and J. Schmidt Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany-limitations of the 'sickest first'-concept Transpl Int 24 2011 91 99
106. P. Dutkowski, C.E. Oberkofler, and K. Slankamenac Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era Ann Surg 254 2011 745 753 discussion 753
107. R.M. Merion, D.E. Schaubel, and D.M. Dykstra The survival benefit of liver transplantation Am J Transplant 5 2005 307 313
108. D.E. Schaubel, M.K. Guidinger, and S.W. Biggins Survival benefit-based deceased-donor liver allocation Am J Transplant 9 2009 970 981
109. J. Neuberger What is the real gain after liver transplantation? Liver Transpl 15 suppl 2 2009 S1 S5
110. J. Briceno, R. Ciria, and M. de la Mata Donor-recipient matching: myths and realities J Hepatol 58 2013 811 820
111. L. Roels, and A. Rahmel The European experience Transpl Int 24 2011 350 367
112. C. Peralta, M.B. Jimenez-Castro, and J. Gracia-Sancho Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu J Hepatol 59 2013 1094 1106
113. R.W. Busuttil, and K. Tanaka The utility of marginal donors in liver transplantation Liver Transpl 9 2003 651 663
114. A. Nocito, A.M. El-Badry, and P.A. Clavien When is steatosis too much for transplantation? J Hepatol 45 2006 494 499
115. A.L. Spitzer, O.B. Lao, and A.A. Dick The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment Liver Transpl 16 2010 874 884
116. P. Dutkowski, A. Schlegel, and K. Slankamenac The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score Ann Surg 256 2012 861 868 discussion 868-869
117. A.K. Mathur, J. Heimbach, and D.E. Steffick Donation after cardiac death liver transplantation: predictors of outcome Am J Transplant 10 2010 2512 2519
118. C.B. Taner, I.G. Bulatao, and D.K. Perry Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors Transpl Int 25 2012 838 846
119. S. Feng, N.P. Goodrich, and J.L. Bragg-Gresham Characteristics associated with liver graft failure: the concept of a donor risk index Am J Transplant 6 2006 783 790
120. A.E. Braat, J.J. Blok, and H. Putter The Eurotransplant donor risk index in liver transplantation: ET-DRI Am J Transplant 12 2012 2789 2796
121. J.B. Halldorson, R. Bakthavatsalam, and O. Fix D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching Am J Transplant 9 2009 318 326
122. A.W. Avolio, J.B. Halldorson, and P. Burra Balancing utility and need by means of donor-to-recipient matching: a challenging problem Am J Transplant 13 2013 522 523
123. A. Rana, M.A. Hardy, and K.J. Halazun Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation Am J Transplant 8 2008 2537 2546
124. A. Rana, T. Jie, and M. Porubsky The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high-risk cohorts Clin Transplant 27 2013 627 632
125. R.M. Ghobrial, J. Gornbein, and R. Steadman Pretransplant model to predict posttransplant survival in liver transplant patients Ann Surg 236 2002 315 322 discussion 322-323
126. H. Petrowsky, A. Rana, and F.M. Kaldas Liver transplantation in highest acuity recipients: identifying factors to avoid futility Ann Surg 259 2014 1186 1194
127. M. Attia, M.A. Silva, and D.F. Mirza The marginal liver donor - an update Transpl Int 21 2008 713 724
128. D. Monbaliu, and J. Brassil Machine perfusion of the liver: past, present and future Curr Opin Organ Transplant 15 2010 160 166
129. C. Bae, S.D. Henry, and J.V. Guarrera Is extracorporeal hypothermic machine perfusion of the liver better than the 'good old icebox'? Curr Opin Organ Transplant 17 2012 137 142
130. T. Minor, and A. Paul Hypothermic reconditioning in organ transplantation Curr Opin Organ Transplant 18 2013 161 167
131. S. Op den Dries, N. Karimian, and R.J. Porte Normothermic machine perfusion of discarded liver grafts Am J Transplant 13 2013 2504
132. R. Bellomo, B. Marino, and G. Starkey Normothermic extracorporeal human liver perfusion following donation after cardiac death Crit Care Resusc 15 2013 78 82
133. BBC News Health. "Warmed liver"transplant first. Available at: www.bbc.com/news/health-21788533.
134. C. Fondevila, A.J. Hessheimer, and E. Flores Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation Am J Transplant 12 2012 162 170
135. B.G. Bruinsma, T.A. Berendsen, and M.L. Izamis Determination and extension of the limits to static cold storage using subnormothermic machine perfusion Int J Artif Organs 36 2013 775 780
136. J.V. Guarrera, J. Estevez, and J. Boykin Hypothermic machine perfusion of liver grafts for transplantation: technical development in human discard and miniature swine models Transplant Proc 37 2005 323 325
137. J.V. Guarrera, S.D. Henry, and B. Samstein Hypothermic machine preservation in human liver transplantation: the first clinical series Am J Transplant 10 2010 372 381
138. A. Jomaa, K. Gurusamy, and P.N. Siriwardana Does hypothermic machine perfusion of human donor livers affect risks of sinusoidal endothelial injury and microbial infection? A feasibility study assessing flow parameters, sterility, and sinusoidal endothelial ultrastructure Transplant Proc 45 2013 1677 1683
139. D. Monbaliu, Q. Liu, and L. Libbrecht Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers Liver Transpl 18 2012 1495 1507
140. K. Vekemans, J. van Pelt, and M. Komuta Attempt to rescue discarded human liver grafts by end ischemic hypothermic oxygenated machine perfusion Transplant Proc 43 2011 3455 3459
141. P. Dutkowski, B. Odermatt, and T. Heinrich Hypothermic oscillating liver perfusion stimulates ATP synthesis prior to transplantation J Surg Res 80 1998 365 372
142. P. Dutkowski, R. Graf, and P.A. Clavien Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion Am J Transplant 6 2006 903 912
143. P. Dutkowski, K. Furrer, and Y. Tian Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor Ann Surg 244 2006 968 976 discussion 976-977
144. O. de Rougemont, S. Breitenstein, and B. Leskosek One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death Ann Surg 250 2009 674 683
145. A. Schlegel, R. Graf, and P.A. Clavien Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation J Hepatol 59 2013 984 991
146. P. Dutkowski, A. Schlegel, and M. de Oliveira HOPE for human liver grafts obtained from donors after cardiac death J Hepatol 60 2014 765 772
147. E.A. Pomfret, R.S. Sung, and J. Allan Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium Am J Transplant 8 2008 745 752
148. S.G. Lee Living-donor liver transplantation in adults Br Med Bull 94 2010 33 48
149. C.L. Berg, B.W. Gillespie, and R.M. Merion Improvement in survival associated with adult-to-adult living donor liver transplantation Gastroenterology 133 2007 1806 1813
150. Y. Harihara, M. Makuuchi, and H. Kawarasaki Initial experience with living-related liver transplantation at the University of Tokyo Transplant Proc 30 1998 129 131
151. K. Waki, Y. Sugawara, and K. Mizuta Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance Clin Transpl 2011 223 235
152. A.D. Muzaale, N.N. Dagher, and R.A. Montgomery Estimates of early death, acute liver failure, and long-term mortality among live liver donors Gastroenterology 142 2012 273 280
153. B. Ringe, and R.W. Strong The dilemma of living liver donor death: to report or not to report? Transplantation 85 2008 790 793
154. M. Abradelo, R. Sanabria, and O. Caso Split liver transplantation: where? when? how? Transplant Proc 44 2012 1513 1516
155. K.W. Lee, A.M. Cameron, and W.R. Maley Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base Am J Transplant 8 2008 1186 1196
156. J.F. Renz, J.C. Emond, and H. Yersiz Split-liver transplantation in the United States: outcomes of a national survey Ann Surg 239 2004 172 181
157. S. Breitenstein, C. Apestegui, and H. Petrowsky "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers World J Surg 33 2009 797 803
158. R. Taub Liver regeneration: from myth to mechanism Nat Rev Mol Cell Biol 5 2004 836 847
159. A.W. Duncan, C. Dorrell, and M. Grompe Stem cells and liver regeneration Gastroenterology 137 2009 466 481
160. G.K. Michalopoulos Principles of liver regeneration and growth homeostasis Compr Physiol 3 2013 485 513
161. F. Dahm, P. Georgiev, and P.A. Clavien Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications Am J Transplant 5 2005 2605 2610
162. M. Bolognesi, D. Sacerdoti, and G. Bombonato Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size Hepatology 35 2002 601 608
163. S. Ueno, Y. Kobayashi, and K. Kurita Effect of prior portosystemic shunt on early hepatic hemodynamics and sinusoids following 84% hepatectomy in dogs Res Exp Med (Berl) 195 1995 1 8
164. A.J. Demetris, D.M. Kelly, and B. Eghtesad Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome Am J Surg Pathol 30 2006 986 993
165. K. Lehmann, C. Tschuor, and A. Rickenbacher Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration Gastroenterology 143 2012 1609 1619.e4
166. Y. Sato, T. Ichida, and S. Yamamoto Shear stress theory and small-for-size graft in adult living related liver transplantation Transplant Proc 35 2003 78
167. O. Boillot, B. Delafosse, and I. Mechet Small-for-size partial liver graft in an adult recipient;a new transplant technique Lancet 359 2002 406 407
168. Y. Ogura, T. Hori, and W.M. El Moghazy Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before Liver Transpl 16 2010 718 728
169. P.A. Clavien, M. Selzner, and H.A. Rudiger A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning Ann Surg 238 2003 843 850 discussion 851-852
170. H. Petrowsky, L. McCormack, and M. Trujillo A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection Ann Surg 244 2006 921 928 discussion 928-930
171. M. Wang, J. Shen, and B. Feng Remote ischemic preconditioning promotes early liver cell proliferation in a rat model of small-for-size liver transplantation J Surg Res 179 2013 e245 e253
172. H. Jaeschke, and B.L. Woolbright Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species Transplant Rev (Orlando) 26 2012 103 114
173. B. Beck-Schimmer, S. Breitenstein, and S. Urech A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic Ann Surg 248 2008 909 918
174. H. Petrowsky, S. Breitenstein, and K. Slankamenac Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection Ann Surg 252 2010 813 822
175. A. Taki-Eldin, L. Zhou, and H.Y. Xie Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats J Hepatobiliary Pancreat Sci 2011 May 17 [Epub ahead of print]
176. T. Onoe, Y. Tanaka, and K. Ide Attenuation of portal hypertension by continuous portal infusion of PGE1 and immunologic impact in adult-to-adult living-donor liver transplantation Transplantation 95 2013 1521 1527
177. X. Xu, K. Man, and S.S. Zheng Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival Liver Transpl 12 2006 621 627
178. Y. Ji, U. Dahmen, and N. Madrahimov G-CSF administration in a small-for-size liver model J Invest Surg 22 2009 167 177
179. W. Huang, K. Ma, and J. Zhang Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration Science 312 2006 233 236
180. M.C. Londono, M.C. Lopez, and A. Sanchez-Fueyo Minimization of immunosuppression in adult liver transplantation: new strategies and tools Curr Opin Organ Transplant 15 2010 685 690
181. M.C. Londono, A. Rimola, and J. O'Grady Immunosuppression minimization vs. complete drug withdrawal in liver transplantation J Hepatol 59 2013 872 879
182. P.M. Porrett, S.K. Hashmi, and A. Shaked Immunosuppression: trends and tolerance? Clin Liver Dis 18 2014 687 716